Vivendo Pharma

Vivendo Pharma

Zug, Switzerland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Vivendo Pharma is a private Swiss consultancy and licensing firm founded by pharmaceutical industry experts. Its core business is developing, managing, and licensing regulatory dossiers and IP for pharmaceutical products, including biosimilars, generics, and novel formulations in therapeutic areas like ophthalmology, osteoarthritis, and wound care. The company generates revenue through partnership and licensing deals with international distributors, positioning itself as a bridge between innovation and market registration without engaging in manufacturing or commercial sales. It maintains a pre-revenue or early-revenue status dependent on successful deal closures.

OphthalmologyOsteoarthritisWound Care

Technology Platform

Integrated service model for regulatory dossier development and IP management, specializing in EU-compliant dossiers for pharmaceuticals, biotech, and medical devices.

Opportunities

Growing global demand for biosimilars and generics creates a need for expert regulatory services.
Vivendo's EU-focused expertise is a valuable asset for distributors in emerging markets like Asia and MENA seeking high-quality, compliant dossiers.

Risk Factors

Revenue is entirely dependent on successful licensing deals, creating significant business model risk.
Changes in complex EU regulations could require costly dossier updates, and the company's reputation is tied to the performance of its distribution partners.

Competitive Landscape

Competes with larger regulatory consulting firms and Contract Research Organizations (CROs) that offer dossier development services. Its differentiation lies in its specialized, partner-centric licensing model and focus on a curated portfolio of advanced pharmaceutical dossiers.